Mosaic ImmunoEngineering Inc.
CPMV · OTCMCIK 836564fmd_0EPE51DXAYGBA6W5NP9YWD6P7MManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Dec 01, 2009 to Jun 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | – | – | – | 1 | 1 | 0 | 0 | 0 |
| Selling, general and administrative | 2 | 1 | 1 | 1 | 1 | – | – | – | – | – |
| Total operating expenses | 2 | 1 | 1 | 1 | 1 | 4 | 3 | 1 | 1 | 1 |
| Non-interest expense | – | – | – | – | – | 0 | 0 | 0 | – | – |
| Operating income | – | – | – | – | – | (4) | (3) | (1) | (1) | (1) |
| Interest expense | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | 1 | (0) | (0) | (0) | (0) | 0 | 0 | (0) | (0) |
| Income before taxes | (1) | (0) | (1) | (1) | (1) | (4) | (2) | (1) | (1) | (1) |
| Income tax expense | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (1) | (0) | (1) | (1) | (1) | (4) | (2) | (1) | (1) | (1) |
| Net income | (1) | (0) | (1) | (1) | (1) | (4) | (2) | (1) | (1) | (1) |